Xopenex HFA

Name	Levalbuterol Tartrate
Synonyms	Xopenex HFA UNII-ADS4I3E22M Levalbuterol tartrate Levalbuterol Tartrate Levosalbutamol tartrate Levalbuterol tartrate [USP] Levalbuterol tartrate (Levosalbutamol tartrate) (R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxy-methyl)phenol (2R,3R)-2,3-dihydroxysucci (R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxy-methyl)phenol (2R,3R)-2,3-dihydroxysuccinat
CAS	661464-94-4
InChI	InChI=1/C13H21NO3.C6H10O4/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-3(5(7)8)4(2)6(9)10/h4-6,12,14-17H,7-8H2,1-3H3;3-4H,1-2H3,(H,7,8)(H,9,10)/t12-;3-,4-/m01/s1

Molecular Formula	C17H27NO9
Molar Mass	389.39758
Storage Condition	Room Temprature
In vivo study	In children with asthma, after 1 hour of continuous treatment with Racemic albuterol (3.75 mg, bid), compared with the administration of Levalbuterol (7.5 mg, bid), improved their forced expiratory volume in 1 second (FEV1) and asthma severity. The dramatic improvement in asthma symptoms was maintained after the second hour of continuous treatment in the racemic albuterol group, but the improvement in forced expiratory volume (FEV1) measurements within 1 second disappeared. In patients with asthma or chronic obstructive pulmonary disease (COPD), Levalbuterol (2.5 mg) requires significantly less mean total and predetermined aerosolized dose compared to racemic albuterol (1.25 mg). In the levalbuterol (1.25 mg) and racemic albuterol (2.5 mg) treatment groups, there was a significant increase from baseline in the disease symptom assessment and in the subject's general well-being score, the average score of β-mediated adverse reactions in the levalbuterol group was significantly higher than that in the racemic albuterol group.

Product Name: Xopenex HFA Visit Supplier Webpage Request for quotation
CAS: 661464-94-4
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

Product Name: Xopenex HFA Visit Supplier Webpage Request for quotation
CAS: 661464-94-4
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

View History

Xopenex HFA

Xopenex HFA Request for Quotation